Role of Beta-arrestin-1 and Src in nAChR Signaling and Lung Caancer
Beta-arrestin-1 和 Src 在 nAChR 信号传导和肺癌中的作用
基本信息
- 批准号:7763269
- 负责人:
- 金额:$ 34.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-17 至 2013-01-31
- 项目状态:已结题
- 来源:
- 关键词:A549AccountingAdhesionsAffectApoptosisApoptoticArrestin Beta 1BiochemicalBiological AssayBlood VesselsButanonesCarcinogensCardiovascular DiseasesCell Culture SystemCell LineCell NucleusCell ProliferationCellsColorectal CancerDevelopmentDiseaseEpithelialEventExposure toFunctional disorderG Protein-Coupled Receptor SignalingGene ExpressionGene Expression RegulationGrowthImmigrationIn VitroLeadLightLungLung NeoplasmsMalignant Epithelial CellMalignant NeoplasmsMalignant neoplasm of lungMediatingMesenchymalMolecularMolecular TargetMusN&apos-nitrosonornicotineNeoplasm MetastasisNeurogliaNicotineNicotinic ReceptorsNon-Small-Cell Lung CarcinomaNuclear TranslocationOncogenicPatientsPlayProcessPropertyProteinsRelative (related person)ReportingResistanceRoleScaffolding ProteinSignal TransductionSmokerSmokingSystemTobaccoTobacco smokeTobacco useTobacco-Associated CarcinogenTranscriptional ActivationTumor Cell InvasionTyrosine Phosphorylationangiogenesisarrestin 1basecancer cellchemotherapeutic agentcigarette smokingcombatcomputerized data processingin vivoinsightmouse modelnovelpromoterpublic health relevancereceptorresearch studyresponsesmoking cessationsrc-Family Kinasestissue/cell culturetumortumor growthtumor progressiontumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Cigarette smoking is strongly correlated with onset of lung cancer and cardiovascular diseases. About 60% of non-small cell lung carcinomas (NSCLCs) arise as a result of smoking. Nicotine and structurally related tobacco carcinogens like 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N'-nitrosonornicotine (NNN) have been found to induce the proliferation of cell lines derived from lung cancers. In addition, these agents could induce angiogenesis in vitro and in vivo and confer resistance to apoptosis. These events are mediated through the activation of the nicotinic acetylcholine receptors (nAChRs), and nAChRs have been detected in a variety of non-neuronal cells. Nicotine by itself is not known to induce oncogenesis; but based on its ability to induce tumor growth and angiogenesis, we propose to study how nicotine affects the growth, progression and metastasis of non-small cell lung carcinomas. Our recent results show that the scaffolding protein ¿-arrestin-1 plays a major role in mediating the proliferative signals of nAChRs and was necessary for activation of Src in response to nAChR stimulation. Further, nicotine stimulation of A549 cells led to changes in the expression of genes involved in epithelial-mesenchymal transition (EMT). Recent studies have shown that ¿-arrestin-1 plays a significant role in the metastasis of colorectal cancers. Given this background, we will assess the role of ¿-arrestin-1 and Src in nicotine-induced cell proliferation, tumor cell invasion, metastasis and angiogenesis. It has been reported that ¿-arrestin-1 translocates to the nucleus in response to G-protein coupled receptor signaling and activates multiple promoters; we find a similar nuclear translocation upon nicotine stimulation. Our preliminary results show that nAChR stimulation of non-small cell lung carcinoma cells leads to transcriptional activation of promoters involved in proliferation and EMT; we will assess the contribution of ¿-arrestin-1 to this process. Based on our finding that nicotine can promote the growth of non-small cell lung tumors in mice, we will examine whether nicotine promotes tumor progression and metastasis in three different mouse models. Underlying mechanisms facilitating these processes will be elucidated, including the contribution of ¿-arrestin-1 and Src in nicotine-induced tumor metastasis. Since a majority of non-small cell lung carcinomas correlate with exposure to tobacco smoke, these studies will throw light on the molecular mechanisms by which nicotine affects the growth and progression of lung cancers. PUBLIC HEALTH RELEVANCE: Exposure to tobacco smoke is highly correlated with onset of lung cancer. Though it is the direct effect of tobacco carcinogens that initiate tumor formation, exposure to nicotine might facilitate the growth and progression of tumors already formed. This is especially relevant since many smokers use nicotine supplements to quit smoking. The studies proposed in this application will elucidate the mechanisms by which nicotine induces cell proliferation, tumor growth and spread, as well as formation of new blood vessels. These studies can be expected to lead to the development of novel agents to combat cancer.
描述(由申请人提供):吸烟与肺癌和心血管疾病的发病密切相关。 大约 60% 的非小细胞肺癌 (NSCLC) 是由吸烟引起的。 尼古丁和结构相关的烟草致癌物如 4-(甲基亚硝基氨基)-1-(3-吡啶基)-1-丁酮 (NNK) 和 N'-亚硝基降烟碱 (NNN) 已被发现可诱导肺癌细胞系的增殖。 此外,这些药物可以在体外和体内诱导血管生成并赋予细胞凋亡抵抗力。 这些事件是通过烟碱乙酰胆碱受体 (nAChR) 的激活介导的,并且已在多种非神经元细胞中检测到 nAChR。 目前尚不清楚尼古丁本身会诱发肿瘤发生。但基于其诱导肿瘤生长和血管生成的能力,我们建议研究尼古丁如何影响非小细胞肺癌的生长、进展和转移。 我们最近的结果表明,支架蛋白 ¿-arrestin-1 在介导 nAChR 的增殖信号中起主要作用,并且是响应 nAChR 刺激而激活 Src 所必需的。 此外,尼古丁刺激 A549 细胞会导致参与上皮间质转化 (EMT) 的基因表达发生变化。 最近的研究表明,¿-arrestin-1在结直肠癌的转移中发挥着重要作用。 鉴于此背景,我们将评估 ¿-arrestin-1 和 Src 在尼古丁诱导的细胞增殖、肿瘤细胞侵袭、转移和血管生成中的作用。 据报道,¿-arrestin-1 响应 G 蛋白偶联受体信号传导而易位至细胞核,并激活多个启动子;我们在尼古丁刺激下发现了类似的核易位。 我们的初步结果表明,nAChR 刺激非小细胞肺癌细胞会导致参与增殖和 EMT 的启动子转录激活;我们将评估 ¿-arrestin-1 对这一过程的贡献。 基于我们发现尼古丁可以促进小鼠非小细胞肺癌的生长,我们将在三种不同的小鼠模型中研究尼古丁是否促进肿瘤的进展和转移。 将阐明促进这些过程的潜在机制,包括 ¿-arrestin-1 和 Src 在尼古丁诱导的肿瘤转移中的作用。由于大多数非小细胞肺癌与接触烟草烟雾有关,这些研究将揭示尼古丁影响肺癌生长和进展的分子机制。 公共卫生相关性:接触烟草烟雾与肺癌的发病高度相关。 尽管烟草致癌物质的直接作用引发了肿瘤的形成,但接触尼古丁可能会促进已形成的肿瘤的生长和进展。 这尤其重要,因为许多吸烟者使用尼古丁补充剂来戒烟。 本申请中提出的研究将阐明尼古丁诱导细胞增殖、肿瘤生长和扩散以及新血管形成的机制。 这些研究有望导致抗癌新药的开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SRIKUMAR P. CHELLAPPAN其他文献
SRIKUMAR P. CHELLAPPAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SRIKUMAR P. CHELLAPPAN', 18)}}的其他基金
CARM1-mediated regulation of YAP1 as a therapeutic target in lung cancer
CARM1 介导的 YAP1 调节作为肺癌的治疗靶点
- 批准号:
10226339 - 财政年份:2020
- 资助金额:
$ 34.65万 - 项目类别:
TBK1 mediated regulation of E2F1 as a therapeutic target in non-small cell lung cancer
TBK1 介导的 E2F1 调节作为非小细胞肺癌的治疗靶点
- 批准号:
9059672 - 财政年份:2015
- 资助金额:
$ 34.65万 - 项目类别:
TBK1 mediated regulation of E2F1 as a therapeutic target in non-small cell lung cancer
TBK1 介导的 E2F1 调节作为非小细胞肺癌的治疗靶点
- 批准号:
8881670 - 财政年份:2015
- 资助金额:
$ 34.65万 - 项目类别:
Role of Id1 in NSCLC Progression and Metastasis
Id1 在 NSCLC 进展和转移中的作用
- 批准号:
8193233 - 财政年份:2009
- 资助金额:
$ 34.65万 - 项目类别:
Role of Id1 in NSCLC Progression and Metastasis
Id1 在 NSCLC 进展和转移中的作用
- 批准号:
8385488 - 财政年份:2009
- 资助金额:
$ 34.65万 - 项目类别:
Role of Id1 in NSCLC Progression and Metastasis
Id1 在 NSCLC 进展和转移中的作用
- 批准号:
7665277 - 财政年份:2009
- 资助金额:
$ 34.65万 - 项目类别:
Role of Beta-arrestin-1 and Src in nAChR Signaling and Lung Caancer
Beta-arrestin-1 和 Src 在 nAChR 信号传导和肺癌中的作用
- 批准号:
7466802 - 财政年份:2008
- 资助金额:
$ 34.65万 - 项目类别:
Role of Beta-arrestin-1 and Src in nAChR Signaling and Lung Caancer
Beta-arrestin-1 和 Src 在 nAChR 信号传导和肺癌中的作用
- 批准号:
7615031 - 财政年份:2008
- 资助金额:
$ 34.65万 - 项目类别:
Role of Beta-arrestin-1 and Src in nAChR Signaling and Lung Caancer
Beta-arrestin-1 和 Src 在 nAChR 信号传导和肺癌中的作用
- 批准号:
8208242 - 财政年份:2008
- 资助金额:
$ 34.65万 - 项目类别:
Role of Beta-arrestin-1 and Src in nAChR Signaling and Lung Caancer
Beta-arrestin-1 和 Src 在 nAChR 信号传导和肺癌中的作用
- 批准号:
8016094 - 财政年份:2008
- 资助金额:
$ 34.65万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 34.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 34.65万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 34.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 34.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 34.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 34.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 34.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 34.65万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 34.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 34.65万 - 项目类别:














{{item.name}}会员




